Literature DB >> 11223999

Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995.

C Gasse1, H W Hense, J Stieber, A Döring, A D Liese, U Keil.   

Abstract

OBJECTIVE: To assess trends in prevalence and detection, treatment and control of hypertension in a German population between 1984 and 1995. SETTING AND PARTICIPANTS: Independent random samples of the population were examined in cross-sectional surveys with identical methods in 1984/85 (age range 25 to 64 years, n = 4022 participants), 1989/90 (age range 25 to 74 years, n = 4940) and 1994/95 (age range 25 to 74 years, n = 4856). MAIN OUTCOME MEASURES: Prevalence of hypertension and proportions of hypertensives detected, treated and controlled. Hypertension was defined as blood pressure above 140/90 mm Hg or taking antihypertensive medication.
RESULTS: The prevalence of hypertension did not change significantly over the 10 years (25--64 years, age-standardised 1984/85: 37.8% in men and 24.6% in women; 1994/95: 39.3% and 24.8%, respectively). Rates of detection, treatment and control of hypertension did not change much either. Of all hypertensives in 1994/95, 54% were detected in men and 64% in women, the treatment rates were 23% and 32%, and the proportions of those with controlled hypertension (below 140/90 mm Hg with treatment) were as low as 7% and 13%, respectively. Rates were higher in the older age groups, however, control rates never exceeded 20% at any age.
CONCLUSIONS: Despite considerable changes in the pharmacological treatment of hypertension there was a disappointing stagnation with regard to the management of this important risk factor in the community. The reasons for this unfavourable trend need clarification and appropriate public health action. Journal of Human Hypertension (2001) 15, 27-36

Entities:  

Mesh:

Year:  2001        PMID: 11223999     DOI: 10.1038/sj.jhh.1001120

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  16 in total

1.  [Prevalence of arterial hypertension in the population of Western Germany: Heinz Nixdorf Recall Study].

Authors:  M Horacek; S Möhlenkamp; A A Mahabadi; S Churzidse; S Moebus; K-H Jöckel; R Erbel
Journal:  Herz       Date:  2012-11       Impact factor: 1.443

2.  Influence of a single dose of 20 mg tadalafil, a phosphodiesterase 5 inhibitor, on ambulatory blood pressure in subjects with hypertension.

Authors:  Dean Patterson; Gordon T McInnes; John Webster; Malcolm M Mitchell; Thomas M Macdonald
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

3.  Trends in hypertension management in Type I diabetes across Europe, 1989/1990 - 1997/1999.

Authors:  S S Soedamah-Muthu; H M Colhoun; H Abrahamian; N N Chan; R Mangili; G P Reboldi; J H Fuller
Journal:  Diabetologia       Date:  2002-09-07       Impact factor: 10.122

Review 4.  Gender differences in the metabolic syndrome and their role for cardiovascular disease.

Authors:  V Regitz-Zagrosek; E Lehmkuhl; M O Weickert
Journal:  Clin Res Cardiol       Date:  2006-01-30       Impact factor: 5.460

5.  Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany.

Authors:  Sebastian Harder; Philipp Fischer; Markus Krause-Schäfer; Klaus Ostermann; Gottfried Helms; Helge Prinz; Mike Hahmann; Horst Baas
Journal:  Eur J Clin Pharmacol       Date:  2004-12-01       Impact factor: 2.953

6.  PPARα in Obesity: Sex Difference and Estrogen Involvement.

Authors:  Michung Yoon
Journal:  PPAR Res       Date:  2010-08-17       Impact factor: 4.964

Review 7.  [Heart failure--are there gender aspects?].

Authors:  V Regitz-Zagrosek; E Lehmkuhl; H B Lehmkuhl
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

8.  Differential control of systolic and diastolic blood pressure in blacks with essential hypertension.

Authors:  Olugbenga E Ayodele; C Olutayo Alebiosu; Babatunde L Salako
Journal:  J Natl Med Assoc       Date:  2004-03       Impact factor: 1.798

9.  Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patients.

Authors:  Alexander Michael Labeit; Jens Klotsche; Lars Pieper; David Pittrow; Franziska Einsle; Günter Karl Stalla; Hendrik Lehnert; Sigmund Silber; Andreas Michael Zeiher; Winfried März; Martin Wehling; Hans-Ulrich Wittchen
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation.

Authors:  Ina-Maria Rückert; Werner Maier; Andreas Mielck; Sabine Schipf; Henry Völzke; Alexander Kluttig; Karin-Halina Greiser; Klaus Berger; Grit Müller; Ute Ellert; Hannelore Neuhauser; Wolfgang Rathmann; Teresa Tamayo; Susanne Moebus; Silke Andrich; Christa Meisinger
Journal:  Cardiovasc Diabetol       Date:  2012-10-05       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.